BioMed Raises $177M to Accelerate Next-Gen Biologics Development
Harbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,
Read moreHarbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,
Read moreAbbVie, Harbour BioMed, Utrecht University and the Erasmus Medical Center (EMC) revealed today they have entered into a partnership to
Read moreWatlow, an industry pioneer in the design and manufacture of complete thermal systems, has recently launched a batch processing feature
Read moreNubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read moreDeciphera Pharmaceuticals, Inc. has revealed that QINLOCK™ (ripretinib) was formally authorised by the U.S. Food and Drug Administration (FDA) for
Read moreThe new 2060 Process Analyzer by Metrohm Process Analytics offers customized online monitoring of critical chemical parameters in industrial processes
Read moreJapanese research-driven pharmaceutical company Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. announced on April 28 that the
Read moreARTES Biotechnology, a Germany-based biotechnology company specialising in process development for recombinant vaccines, has commenced the development of SARS-CoV-2 vaccine
Read moreThe first intermediate analysis of the Phase I Zika vaccine candidate sample (mRNA-1893) reveals that the dosage levels of 10
Read moreItalian IT and complex database consultancy Nubilaria is offering it’s cutting edge ACTide EDC web platform free of charge to
Read more